Your browser doesn't support javascript.
loading
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in Asia.
Seko, Yuya; Kawanaka, Miwa; Fujii, Hideki; Iwaki, Michihiro; Hayashi, Hideki; Toyoda, Hidenori; Oeda, Satoshi; Hyogo, Hideyuki; Morishita, Asahiro; Munekage, Kensuke; Kawata, Kazuhito; Yamamura, Sakura; Sawada, Koji; Maeshiro, Tatsuji; Tobita, Hiroshi; Yoshida, Yuichi; Naito, Masafumi; Araki, Asuka; Arakaki, Shingo; Kawaguchi, Takumi; Noritake, Hidenao; Ono, Masafumi; Masaki, Tsutomu; Yasuda, Satoshi; Tomita, Eiichi; Yoneda, Masato; Tokushige, Akihiro; Kamada, Yoshihiro; Takahashi, Hirokazu; Ueda, Shinichiro; Aishima, Shinichi; Sumida, Yoshio; Okanoue, Takeshi; Itoh, Yoshito; Nakajima, Atsushi.
Afiliación
  • Seko Y; Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kawanaka M; Department of General Internal Medicine 2, Kawasaki Medical Center, Kawasaki Medical School, Kurashiki, Okayama, Japan.
  • Fujii H; Department of Hepatology, Osaka Metropolitan University, Osaka, Japan.
  • Iwaki M; Division of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Hayashi H; Department of Gastroenterology and Hepatology, Gifu Municipal Hospital, Gifu, Japan.
  • Toyoda H; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Oeda S; Liver Center, Saga University Hospital, Saga, Japan.
  • Hyogo H; Department of Laboratory Medicine, Saga University Hospital, Saga, Japan.
  • Morishita A; Department of Gastroenterology, JA Hiroshima Kouseiren General Hospital, Hatsukaichi, Hiroshima, Japan.
  • Munekage K; Life Care Clinic Hiroshima, Hiroshima, Japan.
  • Kawata K; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu, Kagawa, Japan.
  • Yamamura S; Department of Gastroenterology and Hepatology, Kochi Medical School, Kochi, Japan.
  • Sawada K; Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Maeshiro T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Tobita H; Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.
  • Yoshida Y; First Department of Internal Medicine, University of the Ryukyus Hospital, Nishihara, Okinawa, Japan.
  • Naito M; Division of Pathology, Shimane University Hospital, Izumo, Shimane, Japan.
  • Araki A; Department of Gastroenterology and Hepatology, Suita Municipal Hospital, Suita, Osaka, Japan.
  • Arakaki S; Department of Gastroenterology and Hepatology, Suita Municipal Hospital, Suita, Osaka, Japan.
  • Kawaguchi T; Division of Pathology, Shimane University Hospital, Izumo, Shimane, Japan.
  • Noritake H; First Department of Internal Medicine, University of the Ryukyus Hospital, Nishihara, Okinawa, Japan.
  • Ono M; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Masaki T; Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Yasuda S; Division of Innovative Medicine for Hepatobiliary and Pancreatology, Faculty of Medicine, Kagawa University, Takamatsu, Kagawa, Japan.
  • Tomita E; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Takamatsu, Kagawa, Japan.
  • Yoneda M; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Tokushige A; Department of Gastroenterology and Hepatology, Gifu Municipal Hospital, Gifu, Japan.
  • Kamada Y; Division of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Takahashi H; Department of Cardiovascular Medicine and Hypertension, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Ueda S; Department of Advanced Metabolic Hepatology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
  • Aishima S; Liver Center, Saga University Hospital, Saga, Japan.
  • Sumida Y; Department of Clinical Pharmacology and Therapeutics, Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan.
  • Okanoue T; Department of Pathology and Microbiology, Faculty of Medicine, Saga University, Saga, Japan.
  • Itoh Y; Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Nagakute, Aichi, Japan.
  • Nakajima A; Hepatology Center, Saiseikai Suita Hospital, Suita, Osaka, Japan.
J Gastroenterol Hepatol ; 37(12): 2313-2320, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36198983
BACKGROUND AND AIM: Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non-alcoholic fatty liver disease (NAFLD). METHODS: We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy-proven NAFLD. The median follow-up was 4.6 years. RESULTS: The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow-up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors. CONCLUSION: Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age-dependent screening and management strategies is necessary for patients with NAFLD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Clione / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Animals / Humans / Middle aged Idioma: En Revista: J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Clione / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Animals / Humans / Middle aged Idioma: En Revista: J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Australia